135 related articles for article (PubMed ID: 11197067)
1. Metabolism of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-hexafluoro-1 alpha,23(S)25-trihydroxyvitamin D3 in ROS17/2.8 cells transfected with a plasmid expressing CYP24.
Miyahara T; Gomyo S; Ueda Y; Ohyama Y; Sigeno C; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Yamamoto M; Sakuma T; Nemoto N
Xenobiotica; 2000 Nov; 30(11):1055-62. PubMed ID: 11197067
[TBL] [Abstract][Full Text] [Related]
2. Modification of 1 alpha,25-dihydroxyvitamin D3 metabolism by introduction of 26,26,26,27,27,27-hexafluoro atoms in human promyelocytic leukaemia (HL-60) cells: isolation and identification of a novel bioactive metabolite, 26,26,26,27,27,27-hexafluoro-1 alpha,23(S),25-trihydroxyvitamin D3.
Honda A; Nakashima N; Shida Y; Mori Y; Nagata A; Ishizuka S
Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):509-16. PubMed ID: 8240250
[TBL] [Abstract][Full Text] [Related]
3. 1alpha,25-dihydroxyvitamin D3-24-hydroxylase (CYP24) hydroxylates the carbon at the end of the side chain (C-26) of the C-24-fluorinated analog of 1alpha,25-dihydroxyvitamin D3.
Miyamoto Y; Shinki T; Yamamoto K; Ohyama Y; Iwasaki H; Hosotani R; Kasama T; Takayama H; Yamada S; Suda T
J Biol Chem; 1997 May; 272(22):14115-9. PubMed ID: 9162038
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 on the resorption of bone explants ex vivo.
Miyahara T; Harada M; Kozakai A; Matsumoto M; Hashimoto K; Inoue H; Yoda K; Nakatsu T; Kajita S; Yamazaki R; Higuchi S; Kozuka H; Nemoto N
J Nutr Sci Vitaminol (Tokyo); 1999 Jun; 45(3):239-49. PubMed ID: 10524344
[TBL] [Abstract][Full Text] [Related]
5. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
[TBL] [Abstract][Full Text] [Related]
6. Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3.
Harada M; Miyahara T; Miyata M; Tomita I; Okayachi H; Ikemoto Y; Higuchi S; Otomo S; Kozuka H; Ikekawa N
Bone Miner; 1992 Jul; 18(1):41-9. PubMed ID: 1422297
[TBL] [Abstract][Full Text] [Related]
7. Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D.
Honda A; Nakashima N; Mori Y; Katsumata T; Ishizuka S
J Steroid Biochem Mol Biol; 1992 Jan; 41(1):109-12. PubMed ID: 1310414
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
9. Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells.
Kiriyama T; Okamoto S; Ejima E; Kurihara N; Hakeda Y; Ito N; Izumi M; Kumegawa M; Nagataki S
Endocrinology; 1991 Jan; 128(1):81-6. PubMed ID: 1846118
[TBL] [Abstract][Full Text] [Related]
10. Differences in metabolism between 26,26,26,27,27,27-hexafluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3 in cultured neonatal mouse calvaria.
Harada M; Miyahara T; Kajita-Kondo S; Kozakai A; Higuchi S; Otomo S; Kozuka H
Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):183-93. PubMed ID: 7881867
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vitamin D-responsive gene expression by fluorinated analogs of calcitriol in rat osteoblastic ROB-C26 cells.
Miyamoto Y; Shinki T; Ohyama Y; Kasama T; Iwasaki H
J Biochem; 1995 Nov; 118(5):1068-76. PubMed ID: 8749328
[TBL] [Abstract][Full Text] [Related]
12. Effect of substituting fluorine for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3.
Inaba M; Okuno S; Nishizawa Y; Imanishi Y; Katsumata T; Sugata I; Morii H
Biochem Pharmacol; 1993 Jun; 45(11):2331-6. PubMed ID: 8517874
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro pharmacokinetics and metabolism studies of 26,26,26,27,27,27-F6-1,25(OH)2 vitamin D3 (Falecalcitriol) in rat: induction of vitamin D3-24-hydroxylase (CYP24) responsible for 23S-hydroxylation in target tissues and the drop in serum levels.
Komuro S; Sato M; Kanamaru H; Kaneko H; Nakatsuka I; Yoshitake A
Xenobiotica; 1999 Jun; 29(6):603-13. PubMed ID: 10426559
[TBL] [Abstract][Full Text] [Related]
14. Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D3 on bovine parathyroid cells.
Imanishi Y; Inaba M; Seki H; Koyama H; Nishizawa Y; Morii H; Otani S
J Steroid Biochem Mol Biol; 1999; 70(4-6):243-8. PubMed ID: 10622414
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism.
Cross HS; Peterlik M; Reddy GS; Schuster I
J Steroid Biochem Mol Biol; 1997 May; 62(1):21-8. PubMed ID: 9366495
[TBL] [Abstract][Full Text] [Related]
16. Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24.
Sakaki T; Sawada N; Komai K; Shiozawa S; Yamada S; Yamamoto K; Ohyama Y; Inouye K
Eur J Biochem; 2000 Oct; 267(20):6158-65. PubMed ID: 11012668
[TBL] [Abstract][Full Text] [Related]
17. Extensive methylation of CpG island of CYP24 gene in osteoblastic ROS17/2.8 cells.
Ohyama Y; Kusada T; Yamasaki T; Ide H
Nucleic Acids Res Suppl; 2002; (2):249-50. PubMed ID: 12903199
[TBL] [Abstract][Full Text] [Related]
18. Studies on an adherent variant of the human promyelomonocytic HL60 leukaemia cell line that constitutively expresses 25-hydroxyvitamin D3-24-hydroxylase activity which is inhibited by 1 alpha,25-dihydroxyvitamin D3.
Hayes ME; Bayley D; Mawer EB
J Mol Endocrinol; 1991 Dec; 7(3):185-95. PubMed ID: 1777040
[TBL] [Abstract][Full Text] [Related]
19. DNA binding property of vitamin D3 receptors associated with 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3.
Inaba M; Okuno S; Inoue A; Nishizawa Y; Morii H; DeLuca HF
Arch Biochem Biophys; 1989 Jan; 268(1):35-9. PubMed ID: 2463789
[TBL] [Abstract][Full Text] [Related]
20. Human osteoblasts in culture metabolize both 1 alpha, 25-dihydroxyvitamin D3 and its precursor 25-hydroxyvitamin D3 into their respective lactones.
Siu-Caldera ML; Zou L; Ehrlich MG; Schwartz ER; Ishizuka S; Reddy GS
Endocrinology; 1995 Oct; 136(10):4195-203. PubMed ID: 7664636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
